Search research articles
Contact Us
Filters
Showing results (31-40 of 88) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
May 1, 1987
Imidazole anticonvulsants: structure-activity relationships of [(biphenylyloxy)alkyl]imidazoles
D W Robertson, E E Beedle, R Lawson, et al.
Journal of Medicinal Chemistry
|
February 1, 1982
Antiestrogen basicity--activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicity
D W Robertson, J A Katzenellenbogen, J R Hayes, et al.
Molecular Pharmacology
|
December 1, 1986
LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum
R F Kauffman, V G Crowe, B G Utterback, et al.
Journal of Medicinal Chemistry
|
July 1, 1988
Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor
D W Robertson, J H Krushinski, R W Fuller, et al.
Brain Research
|
July 5, 1991
Localization of 5-HT3 receptors in the rat brain using [3H]LY278584
D R Gehlert, S L Gackenheimer, D T Wong, et al.
The Journal of Biological Chemistry
|
March 25, 1981
Interaction of a high affinity anti-estrogen (alpha-[4-pyrrolidinoethoxy]phenyl-4-hydroxy-alpha'-nitrostilbene, CI628M) with uterine estrogen receptors
B S Katzenellenbogen, E J Pavlik, D W Robertson, et al.
Journal of Medicinal Chemistry
|
July 1, 1989
Synthesis of a tritium-labeled indolidan analogue and its use as a radioligand for phosphodiesterase-inhibitor cardiotonic binding sites
D W Robertson, J H Krushinski, B G Utterback, et al.
Neuropharmacology
|
October 1, 1992
Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo
R W Fuller, H D Snoddy, J H Krushinski, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1992
LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis
M L Cohen, D W Robertson, W E Bloomquist, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1991
Quantitative autoradiography of the binding sites for [125I] iodoglyburide, a novel high-affinity ligand for ATP-sensitive potassium channels in rat brain
D R Gehlert, S L Gackenheimer, D E Mais, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 88) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
May 1, 1987
Imidazole anticonvulsants: structure-activity relationships of [(biphenylyloxy)alkyl]imidazoles
D W Robertson, E E Beedle, R Lawson, et al.
Journal of Medicinal Chemistry
|
February 1, 1982
Antiestrogen basicity--activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicity
D W Robertson, J A Katzenellenbogen, J R Hayes, et al.
Molecular Pharmacology
|
December 1, 1986
LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum
R F Kauffman, V G Crowe, B G Utterback, et al.
Journal of Medicinal Chemistry
|
July 1, 1988
Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor
D W Robertson, J H Krushinski, R W Fuller, et al.
Brain Research
|
July 5, 1991
Localization of 5-HT3 receptors in the rat brain using [3H]LY278584
D R Gehlert, S L Gackenheimer, D T Wong, et al.
The Journal of Biological Chemistry
|
March 25, 1981
Interaction of a high affinity anti-estrogen (alpha-[4-pyrrolidinoethoxy]phenyl-4-hydroxy-alpha'-nitrostilbene, CI628M) with uterine estrogen receptors
B S Katzenellenbogen, E J Pavlik, D W Robertson, et al.
Journal of Medicinal Chemistry
|
July 1, 1989
Synthesis of a tritium-labeled indolidan analogue and its use as a radioligand for phosphodiesterase-inhibitor cardiotonic binding sites
D W Robertson, J H Krushinski, B G Utterback, et al.
Neuropharmacology
|
October 1, 1992
Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo
R W Fuller, H D Snoddy, J H Krushinski, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1992
LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis
M L Cohen, D W Robertson, W E Bloomquist, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1991
Quantitative autoradiography of the binding sites for [125I] iodoglyburide, a novel high-affinity ligand for ATP-sensitive potassium channels in rat brain
D R Gehlert, S L Gackenheimer, D E Mais, et al.
Page
of 9